Josh Hall

Doctor of Medicine,  Toronto General - University Health Network 

Location: India

Consulting Services

Journal Manuscript IT-Web-Mobile Technology Sales and Marketing

Areas Of Interest

Pain Service, Acute Body Weights and Measures Cortices, Posterior Parietal Psychiatry, Preventive N-Nitroso-N-butyl-(4-hydroxybutyl)amine Carbonic Acid Ions Fructose 1,6-Bisphosphate Aldolase, Class II Construction Trades Neocortical External Granular Layer Autoimmune Haemolytic Anaemias Turpentine Stress Reponse, Salinity Familial Partial Lipodystrophy, Type 1 Trochlear Nerve Transections Cramps, Nocturnal Leg Allantois Interleukin-6 Receptors, Kainate Escin Cystatins, Kininogen Sarsaparillas, Bristly Delirium, Dementia, Amnestic, Cognitive Disorders Gitelman's Syndrome Archiving, Data OMPase Receptors, Interleukin 13 Moclamine Secretion Systems, Bacterial Malonic-Semialdehyde Dehydrogenase (Acylating) Non-ST Elevated Myocardial Infarction Aedes Crigler-Najar Syndrome Pepsinogens Fosinopril, (1(S*(R*)),2 alpha,4 beta)-Isomer Crocus, Autumn Culture Diseases, Tongue Mambas, Eastern Green Inventors Dermatologic Agents

Professional Narrative

Dr. Josh Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 1997
Medical Writer, Harvard Med 2012

Education

Doctor of medicine, Yale School of Medicine 2000
Master of Science in physician assistant, Yale School of Medicine 2017

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :